...
rvmd-img

Revolution Medicines Inc, Common Stock

RVMD

NSQ

$44.085

-$1.2

(-2.65%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.20B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
670.60K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.40
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$25.93 L
$62.4 H
$44.085

About Revolution Medicines Inc, Common Stock

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRVMDSectorS&P500
1-Week Return4.62%2.44%2.57%
1-Month Return-22.75%-4.49%0.09%
3-Month Return3.26%-8.82%4.76%
6-Month Return17.88%-4.46%9.89%
1-Year Return56.71%3.16%26.47%
3-Year Return70.07%-0.83%25.98%
5-Year Return56.71%35.65%86.34%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue50.04M42.98M29.39M35.38M11.58M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":85.9,"profit":true},{"date":"2021-12-31","value":58.73,"profit":true},{"date":"2022-12-31","value":70.7,"profit":true},{"date":"2023-12-31","value":23.14,"profit":true}]
Cost of Revenue91.75M132.25M7.33M9.66M411.24M[{"date":"2019-12-31","value":22.31,"profit":true},{"date":"2020-12-31","value":32.16,"profit":true},{"date":"2021-12-31","value":1.78,"profit":true},{"date":"2022-12-31","value":2.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(41.71M)(89.27M)22.06M25.72M11.58M[{"date":"2019-12-31","value":-162.16,"profit":false},{"date":"2020-12-31","value":-347.03,"profit":false},{"date":"2021-12-31","value":85.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":45.02,"profit":true}]
Gross Margin(83.36%)(207.68%)75.05%72.71%100.00%[{"date":"2019-12-31","value":-83.36,"profit":false},{"date":"2020-12-31","value":-207.68,"profit":false},{"date":"2021-12-31","value":75.05,"profit":true},{"date":"2022-12-31","value":72.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses104.16M153.68M217.40M293.66M498.76M[{"date":"2019-12-31","value":20.88,"profit":true},{"date":"2020-12-31","value":30.81,"profit":true},{"date":"2021-12-31","value":43.59,"profit":true},{"date":"2022-12-31","value":58.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(54.12M)(110.70M)(188.01M)(258.28M)(487.19M)[{"date":"2019-12-31","value":-5412000000,"profit":false},{"date":"2020-12-31","value":-11069700000,"profit":false},{"date":"2021-12-31","value":-18800800000,"profit":false},{"date":"2022-12-31","value":-25827900000,"profit":false},{"date":"2023-12-31","value":-48718500000,"profit":false}]
Total Non-Operating Income/Expense4.17M4.33M1.83M18.31M94.47M[{"date":"2019-12-31","value":4.41,"profit":true},{"date":"2020-12-31","value":4.59,"profit":true},{"date":"2021-12-31","value":1.94,"profit":true},{"date":"2022-12-31","value":19.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(52.04M)(108.53M)(187.09M)(249.13M)(439.89M)[{"date":"2019-12-31","value":-5203700000,"profit":false},{"date":"2020-12-31","value":-10853000000,"profit":false},{"date":"2021-12-31","value":-18709100000,"profit":false},{"date":"2022-12-31","value":-24912500000,"profit":false},{"date":"2023-12-31","value":-43989100000,"profit":false}]
Income Taxes(4.37M)(371.00K)(7.32M)(420.00K)(3.52M)[{"date":"2019-12-31","value":-437300000,"profit":false},{"date":"2020-12-31","value":-37100000,"profit":false},{"date":"2021-12-31","value":-732000000,"profit":false},{"date":"2022-12-31","value":-42000000,"profit":false},{"date":"2023-12-31","value":-352400000,"profit":false}]
Income After Taxes(47.66M)(108.16M)(179.77M)(248.71M)(436.37M)[{"date":"2019-12-31","value":-4766400000,"profit":false},{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-17977100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false}]
Income From Continuous Operations(47.66M)(108.16M)(187.09M)(248.71M)(436.37M)[{"date":"2019-12-31","value":-4766400000,"profit":false},{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-18709100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(47.66M)(108.16M)(179.77M)(248.71M)(436.37M)[{"date":"2019-12-31","value":-4766400000,"profit":false},{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-17977100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false}]
EPS (Diluted)(6.89)(2.14)(2.56)(3.10)(3.77)[{"date":"2019-12-31","value":-689,"profit":false},{"date":"2020-12-31","value":-214,"profit":false},{"date":"2021-12-31","value":-256,"profit":false},{"date":"2022-12-31","value":-310,"profit":false},{"date":"2023-12-31","value":-377,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RVMD
Cash Ratio 13.98
Current Ratio 14.24

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RVMD
ROA (LTM) -28.56%
ROE (LTM) -47.18%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RVMD
Debt Ratio Lower is generally better. Negative is bad. 0.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.89

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RVMD
Trailing PE NM
Forward PE NM
P/S (TTM) 11055.32
P/B 5.24
Price/FCF NM
EV/R 9083.96
EV/Ebitda NM

FAQs

What is Revolution Medicines Inc share price today?

Revolution Medicines Inc (RVMD) share price today is $44.085

Can Indians buy Revolution Medicines Inc shares?

Yes, Indians can buy shares of Revolution Medicines Inc (RVMD) on Vested. To buy Revolution Medicines Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RVMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Revolution Medicines Inc be purchased?

Yes, you can purchase fractional shares of Revolution Medicines Inc (RVMD) via the Vested app. You can start investing in Revolution Medicines Inc (RVMD) with a minimum investment of $1.

How to invest in Revolution Medicines Inc shares from India?

You can invest in shares of Revolution Medicines Inc (RVMD) via Vested in three simple steps:

  • Click on Sign Up or Invest in RVMD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Revolution Medicines Inc shares
What is Revolution Medicines Inc 52-week high and low stock price?

The 52-week high price of Revolution Medicines Inc (RVMD) is $62.4. The 52-week low price of Revolution Medicines Inc (RVMD) is $25.93.

What is Revolution Medicines Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Revolution Medicines Inc (RVMD) is

What is Revolution Medicines Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Revolution Medicines Inc (RVMD) is 5.24

What is Revolution Medicines Inc dividend yield?

The dividend yield of Revolution Medicines Inc (RVMD) is 0.00%

What is the Market Cap of Revolution Medicines Inc?

The market capitalization of Revolution Medicines Inc (RVMD) is $8.20B

What is Revolution Medicines Inc’s stock symbol?

The stock symbol (or ticker) of Revolution Medicines Inc is RVMD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top